Serum levels of mast cell tryptase, vascular endothelial growth factor and basic fibroblast growth factor in patients with acute pancreatitis

Nursing

Volumn 27, Issue 2, 1997, Pages

  Mentula, Panu ^a,b   Kylänpää, Marja Leena ^b   Kemppainen, Esko ^b   Eklund, Kari K ^b   Orpana, Arto ^b   Puolakkainen, Pauli ^b   Haapiainen, Reijo ^b   Repo, Heikki ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Acute pancreatitis; BFGF; Mast cell; Tryptase; VEGF

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; SERINE PROTEINASE; TRYPTASE; VASCULOTROPIN A;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROIMMUNOASSAY; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PANCREATITIS; PATHOLOGY;

ACUTE DISEASE; ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTOR 2; FLUOROIMMUNOASSAY; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; SERINE ENDOPEPTIDASES; SEVERITY OF ILLNESS INDEX; TRYPTASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2142839700     PISSN: 03604039     EISSN: 15388689     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J Med. 1999; 340:1412-1417.
2. Bradley EL. A clinically based classification system for acute pancreatitis. Arch Surg. 1993; 128:586-590.
3. Tenner S, Sica G, Hughes M, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology. 1997; 113:899-903.
4. De Beaux A, Palmer K, Carter D. Factors influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases. Gut. 1995; 37:121-126.
5. Repine JE. Scientific perspectives on adult respiratory distress syndrome. Lancet. 1992; 339:466-469.
6. Davies M, Hagen P. Systemic inflammatory response syndrome. Br J Surg. 1997; 84:920-935.
7. Pober JS, Gimbrone Jr, MA Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol. 1986; 137:1893-1896.
8. Repo H, Harlan JM. Mechanism and consequences of phagocyte adhesion to endothelium. Ann Med. 1999; 31:156-165.
9. Swank DW, Moore SB. Roles of the neutrophil and other mediators in adult respiratory distress syndrome. Mayo Clin Proc. 1989; 64:1118-1132.
10. Schwartz LB. Mast cells: functions and contents. Curr Opin Immunol. 1994; 6:91-97.
11. Schwartz LB, Metcalfe MD, Miller JS, et al. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med. 1987; 316:1622-1626.
12. Thorlacius H, Raud J, Rosengren-Beezley S, et al. Mast cell activation induces P-selectin-dependent leukocyte rolling and adhesion in postcapillary venules in vivo. Biochem Biophys Res Commun. 1994; 203:1043-1049.
13. Kubes P, Granger DN. Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc Res. 1996; 32:699-708.
14. Molino M, Barnathan ES, Numerof R, et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem. 1997; 7:4043-4049.
15. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000; 407:258-264.
16. Braganza JM. Mast cell: pivotal player in lethal acute pancreatitis. Q J Med. 2000; 93:469-476.
17. Dip M, Zhao X, Wang XD, et al. Role of mast cells in the development of pancreatitis-induced multiple organ dysfunction. Br J Surg. 2002; 89:172-178.
18. Senger DR, Galli SJ, Dvorak AM, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983; 219:983-985.
19. Hippenstiel S, Krüll M, Ikemann A, et al. VEGF induces hyperpermeability by a direct action on endothelial cells. Am J Physiol. 1998; 274:678-684.
20. Shweiki D, Neeman M, Itin A, et al. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis. Proc Natl Acad Sci. 1995; 92:768-772.
21. Cohen T, Nahari D, Cerem LW, et al. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 1996; 271:736-741.
22. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia: modulation of gene expression by nitric oxide. J Clin Invest. 1995; 95:1798-1807.
23. Salven P, Anttonen K, Repo H, et al. Endotoxins induce and interferon α suppresses vascular endothelial growth factor (VEGF) production in human peripheral blood mononuclear cells. FASEB J. 2001; 15:1318-1320.
24. Grutzkau A, Kruger-Krasagakes S, Baumeister H, et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell. 1998; 9:875-884.
25. Dirix LY, Vermeulen PB, Hubens G, et al. Serum fibroblast growth factor and vascular endothelial growth factor and tumor growth kinetics in advanced colorectal cancer. Ann Oncol. 1996; 7:843-848.
26. Kaner RJ, Ladetto JV, Singh R, et al. Lung overexpression of vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol. 2000; 22:657-664.
27. Karmpaliotis D, Kosmidou I, Ingenito EP, et al. Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2002; 283:585-595.
28. Thickett DR, Armstrong L, Christie SJ, et al. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001; 164:1601-1605.
29. Thickett DR, Armstrong L, Millar AB. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med. 2002; 166:1332-1337.
30. Grad S, Ertel W, Keel M, et al. Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn. Clin Chem Lab Med. 1998; 36:379-383.
31. Senger DR, Van de Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 1993; 12:303-324.
32. Reed JA, Albino AP, Mcnutt NS. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest. 1994; 70:48a.
33. Qu Z, Liebler JM, Powers MR, et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and coetaneous hemangioma. Am J Pathol. 1995; 147:564-573.
34. Ebert M, Yokoyama M, Ishiwata T, et al. Alteration of fibroblast growth factor and receptor expression after acute pancreatitis in humans. Pancreas. 1999; 18:240-246.
35. Bradley EL. A clinically based classification system for acute pancreatitis. Arch Surg. 1993; 128:586-590.
36. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13:818-829.
37. Ranson J, Rifkind K, Roses D, et al. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974; 139:69-81.
38. Marshall J, Cook D, Christnou N, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995; 23:1638-1652.
39. Webb NJ, Bottomley MJ, Watson CJ, et al. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci. 1998; 94:395-404.
40. Dittadi R, Meo S, Fabris F, et al. Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments. Int J Biol Markers. 2001; 16:87-96.
41. George ML, Eccles SA, Tutton MG, et al. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res. 2000; 6:3147-3152.
42. Schwartz LB, Yunginger JW, Miller J, et al. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest. 1989; 83:1551-1555.
43. Mukundan C, Gurish MF, Austen KF, et al. Mast cell mediation of muscle and pulmonary injury following hindlimb ischemia-reperfusion. J Histochem Cytochem. 2001; 49:1055-1056.
44. Quist RG, Ton-Nu HT, Lillienau J, et al. Activation of mast cells by bile acids. Gastroenterology. 1991; 101:446-456.
45. Koivisto T, Kaihovaara P, Salaspuro M. Acetaldehyde induces histamine release from purified rat peritoneal mast cells. Life Sci. 1999; 64:183-190.
46. Genovese A, Stellato C, Marcella CV, et al. Role of mast cells, basophils and their mediators in adverse reactions to general anaesthetics and radiocontrast media. Int Arch Allergy Immunol. 1996; 110:13-22.
47. Yonetci N, Oruc N, Ozutemiz AO, et al. Effects of mast-cell stabilization in cerulein-induced acute pancreatitis in rats. Int J Pancreatol. 2001; 29:163-171.
48. Dib M, Zhao X, Wang X, et al. Mast cells contribute to early pancreatitis-induced systemic endothelial barrier dysfunction. Pancreatology. 2002; 2:396-401.
49. Araki Y, Andoh A, Nakamura F, et al. Mast cells may not play a crucial role in the pathogenesis of experimental closed duodenal loop-induced pancreatitis in rats. Pancreas. 2002; 24:298-302.
50. Elsässer HP, Adler G, Kern HF. Fibroblast structure and function during regeneration from hormone-induced acute pancreatitis in the rat. Pancreas. 1989; 4:169-178.
51. Elsässer HP, Adler G, Kern HF. Time course and cellular source of pancreatic regeneration following acute pancreatitis in the rat. Pancreas. 1986; 1:421-429.
52. Hosokawa M, Tsukada H, Fukuda F, et al. Therapeutic effect of basic fibroblast growth factor on experimental pancreatitis in rat. Pancreas. 2000; 20:373-377.